OA 05.05 Brigatinib in Crizotinib-Refractory ALK+ NSCLC:...

Journal of Thoracic Oncology 2017 / 11 Vol. 12; Iss. 11

OA 05.05 Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial

Ahn, M., Camidge, D.R., Tiseo, M., Reckamp, K., Hansen, K., Kim, S., Huber, R., West, H., Groen, H., Hochmair, M., Leighl, N., Gettinger, S., Langer, C., Paz-Ares, L., Smit, E., Kim, E., Reichmann, W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.350
Date:
November, 2017
File:
PDF, 382 KB
english, 2017
Conversion to is in progress
Conversion to is failed